WengYJGan HY LiXHuangYLiZCDengHMet al
With approximately a third of US adults classified as obese or overweight and 26% expressing a desire to lose weight, we could see a considerable decrease in calorie intake if 10% of US adults use these drugs within the next five years
The STRIVE study is an open-label, real-world randomized control trial assessing the financial burden and practical implications of daily liraglutide administration to patients with obesity, prediabetes, T2D, hypertension, and/or OSA (Papamargaritis et al., 2020)
For those uninsured or whose insurance doesnt cover it, the coupon caps the price at $199 per month
It belongs to a broader group of injectable medications commonly discussed alongside Ozempic and Mounjaro in current GLP-1 litigation and weight loss drug safety discussions
Wang X, Chen Y, Wang X, Tian H, Wang Y, Jin J, et al